E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/20/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

World Heart holders tender all outstanding 3% convertibles, warrants for shares

By Jennifer Chiou

New York, July 20 - World Heart Corp. said investors tendered all its outstanding 3% unsecured convertible debentures and all its warrants, both due Sept. 15, 2009, as of the 8 p.m. ET expiration on July 19.

During the offer, the debentures were convertible at a price of $1.25 per share for a total of 10.7 million shares and the warrants for 10.7 million shares were exercisable at $1.00 per share.

Under their original terms, the warrants were exercisable at $1.55 per share while the debentures were convertible at $1.35 per share.

"The tendering of all of the warrants and debentures along with our shareholder approvals at our annual and special meeting yesterday [July 18] allows World Heart to proceed with completion of the strategic acquisition of the assets of MedQuest Products, Inc. and the related financing transaction with Maverick Venture Management," president and chief executive officer Jal S. Jassawalla said in a news release.

"With these transactions, we are broadening our product platform to include rotary and pulsatile next-generation systems to serve the needs of late and end-stage heart failure patients and will have the necessary funding in place to accelerate these important development programs."

At the close of the MedQuest acquisition and financing, World Heart will have eliminated more than $11 million convertible debentures and about $2 million of interest per year until 2009. The debentures and warrants were originally issued in September 2004.

The company also intends to raise $23 million in financing with Maverick Venture Management.

Based in Oakland, Calif., World Heart, a medical device company, will have 55.4 million shares outstanding. Salt Lake City-based MedQuest is also a medical device company and is developing the HeartQuest ventricular assist device.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.